Surgical Treatment of Pancreatic Cancer

被引:92
作者
Loos, Martin [2 ]
Kleeff, Joerg [2 ]
Friess, Helmut [2 ]
Buechler, Markus W. [1 ]
机构
[1] Heidelberg Univ, Dept Gen Surg, D-69120 Heidelberg, Germany
[2] Tech Univ Munich, Dept Surg, Munich, Germany
来源
RECENT ADVANCES IN CLINICAL ONCOLOGY | 2008年 / 1138卷
关键词
pancreas; cancer; pancreatectomy;
D O I
10.1196/annals.1414.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pancreatic cancer is an aggressive disease with an overall 5-year survival rate of less than 5%. Up to date, surgical resection represents the basis of treatment for localized pancreatic cancer and remains the only chance for cure. Due to continuous improvements in surgical techniques and perioperative care, pancreatic resections have evolved into safe surgical procedures with low mortality and acceptable morbidity rates for experienced surgeons in high-volume centers. Recently, more aggressive approaches including extended lymphadenectomy, vascular resection, surgery for metastastic or recurrent disease, and multimodal regimens have been suggested to improve long-term outcome. This article provides an overview on current standard procedures and summarizes new strategies in the surgical treatment of pancreatic cancer.
引用
收藏
页码:169 / 180
页数:12
相关论文
共 116 条
[41]   Neoadjuvant radio-chemotherapy in advanced primarily non-resectable carcinomas of the pancreas [J].
Kastl, S ;
Brunner, T ;
Herrmann, O ;
Riepl, M ;
Fietkau, R ;
Grabenbauer, G ;
Sauer, R ;
Hohenberger, W ;
Klein, P .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2000, 26 (06) :578-582
[42]  
Kausch W., 1912, Beitr Klin Chir, V78, P439, DOI DOI 10.1097/00000658-193510000-00023
[43]   Modified standard pancreaticoduodenectomy for the treatment of pancreatic head cancer [J].
Kawarada, Y ;
Yokoi, H ;
Isaji, S ;
Naganuma, T ;
Tabata, M ;
Machishi, H ;
Das, BC ;
Takahashi, K ;
Murabayashi, K .
DIGESTION, 1999, 60 :120-125
[44]  
KAYAHARA M, 1993, CANCER, V72, P2118, DOI 10.1002/1097-0142(19931001)72:7<2118::AID-CNCR2820720710>3.0.CO
[45]  
2-4
[46]   Management of pancreatic fistulas after pancreaticoduodenectomy - Results in 437 consecutive patients [J].
Kazanjian, KK ;
Hines, OJ ;
Eibl, G ;
Reber, HA .
ARCHIVES OF SURGERY, 2005, 140 (09) :849-854
[47]   Is adjuvant 5-FU-based chemoradiotherapy for resectable pancreatic adenocarcinoma beneficial? A meta-analysis of an unanswered question [J].
Khanna, Amit ;
Walker, Gail R. ;
Livingstone, Alan S. ;
Arheart, Kristopher L. ;
Rocha-Lima, Caio ;
Koniaris, Leonidas G. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2006, 10 (05) :689-697
[48]   Neoadjuvant therapy for pancreatic cancer [J].
Kleeff, J. ;
Friess, H. ;
Buechler, M. W. .
BRITISH JOURNAL OF SURGERY, 2007, 94 (03) :261-262
[49]   Distal pancreatectomy -: Risk factors for surgical failure in 302 consecutive cases [J].
Kleeff, Joerg ;
Diener, Markus K. ;
Z'graggen, Kaspar ;
Hinz, Ulf ;
Wagner, Markus ;
Bachmann, Jeannine ;
Zehetner, Joerg ;
Mueller, Michael W. ;
Friess, Helmut ;
Buechler, Markus W. .
ANNALS OF SURGERY, 2007, 245 (04) :573-582
[50]   Surgery for recurrent pancreatic ductal adenocarcinoma [J].
Kleeff, Joerg ;
Reiser, Carolin ;
Hinz, Ulf ;
Bachmann, Jeannine ;
Debus, Jurgen ;
Jaeger, Dirk ;
Friess, Helmut ;
Buechler, Markus W. .
ANNALS OF SURGERY, 2007, 245 (04) :566-572